Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer Citation: Fukuokaya W, Mori K, Yanagisawa T, et al. Cancer. 2025 Apr 1;131(7):e35819. PMID: 40106307; PMCID: PMC11922167.
The YODA Project